Work

Memantine improves social impairment in youths with autism spectrum disorder

Year: 2025
Type: article
Abstract: Twelve weeks of treatment with memantine resulted in significant improvement in social impairment among youths with autism spectrum disorder, a placebo‐controlled trial has found. Memantine also did not result in significantly more adverse events compared with placebo. Study results were published online Oct. 1, 2025, in JAMA Network Open .
Language: English
Open Access status: bronze
OpenAlex ID: W4416781279
FWCI:
Cites:
Cited by:
Related to: